Patents by Inventor Philippe Valadon

Philippe Valadon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of rapid ligation-independent cloning of DNA and uses thereof
    Patent number: 11578332
    Abstract: The present invention generally relates to improved methods of assembly of two or more DNA fragments, methods of rapid ligation-independent cloning, and kits for rapid ligation-independent cloning and their uses.
    Type: Grant
    Filed: June 5, 2017
    Date of Patent: February 14, 2023
    Inventor: Philippe Valadon
  • METHODS OF RAPID LIGATION-INDEPENDENT CLONING OF DNA AND USES THEROF
    Publication number: 20200017864
    Abstract: The present invention generally relates to improved methods of assembly of two or more DNA fragments, methods of rapid ligation-independent cloning, and kits for rapid ligation-independent cloning and their uses.
    Type: Application
    Filed: June 5, 2017
    Publication date: January 16, 2020
    Inventor: PHILIPPE VALADON
  • Peptides for detecting anti-double stranded DNA antibody and uses thereof
    Patent number: 7517657
    Abstract: The present invention provides a method for identifying a peptide which binds to an anti-double stranded DNA antibody. The present invention also provides a class of peptides identified by the method of the present invention which bind to anti-double stranded DNA antibodies and compositions containing these peptides. The present invention also provides methods for the diagnosis and treatment of systemic lupus erythematosus utilizing the peptides of the present invention.
    Type: Grant
    Filed: May 13, 2005
    Date of Patent: April 14, 2009
    Assignee: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Bruce D. Gaynor, Betty A. Diamond, Matthew D. Scharff, Philippe Valadon
  • Peptides for the treatment and diagnosis of systemic lupus erythematosus
    Publication number: 20050214852
    Abstract: The present invention provides a method for identifying a peptide which binds to an anti-double stranded DNA antibody. The present invention also provides a class of peptides identified by the method of the present invention which bind to anti-double stranded DNA antibodies and compositions containing these peptides. The present invention also provides methods for the diagnosis and treatment of systemic lupus erythematosus utilizing the peptides of the present invention.
    Type: Application
    Filed: May 13, 2005
    Publication date: September 29, 2005
    Inventors: Bruce Gaynor, Betty Diamond, Matthew Scharff, Philippe Valadon
  • Peptides for the treatment and diagnosis of systemic lupus erythematosus
    Patent number: 6932970
    Abstract: The present invention provides a method for identifying a peptide which binds to an anti-double stranded DNA antibody. The present invention also provides a class of peptides identified by the method of the present invention which bind to anti-double stranded DNA antibodies and compositions containing these peptides. The present invention also provides methods for the diagnosis and treatment of systemic lupus erythematosus utilizing the peptides of the present invention.
    Type: Grant
    Filed: April 10, 1997
    Date of Patent: August 23, 2005
    Assignee: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Bruce D. Gaynor, Betty A. Diamond, Matthew D. Scharff, Philippe Valadon
  • Peptides which bind to anti-double stranded DNA antibody
    Patent number: 6001964
    Abstract: The present invention provides a method for identifying a peptide which binds to an anti-double stranded DNA antibody. The present invention also provides a class of peptides identified by the method of the present invention which bind to anti-double stranded DNA antibodies and compositions containing these peptides. The present invention also provides methods for the diagnosis and treatment of systemic lupus erythematosus utilizing the peptides of the present invention.
    Type: Grant
    Filed: September 20, 1995
    Date of Patent: December 14, 1999
    Assignee: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Bruce D. Gaynor, Betty A. Diamond, Matthew D. Scharff, Philippe Valadon